6720456B07Rik Activators

Chemical activators of BRICK1 can engage in a variety of molecular interactions that lead to the activation of this protein, which is pivotal in the regulation of actin assembly. Phosphatidylinositol 4,5-bisphosphate (PIP2) activates BRICK1 by binding to the WAVE regulatory complex, thereby promoting actin nucleation and assembly, pivotal actions of the BRICK1-containing complex. Similarly, Rac1, a small GTPase, directly activates BRICK1 through its interaction with the WAVE complex, triggering conformational changes that stimulate the complex's actin-nucleating activity. GTPγS, a non-hydrolyzable GTP analog, also contributes to BRICK1 activation by maintaining GTPases like Rac1 in an active state, which subsequently activate the WAVE complex. Moreover, Jasplakinolide, by stabilizing actin filaments, increases the available pool of actin monomers, enhancing the actin polymerization activity of complexes involving BRICK1.

Another route to BRICK1 activation involves intracellular signaling pathways that indirectly influence BRICK1's role in actin polymerization. For instance, N6,2'-O-Dibutyryladenosine 3',5'-cyclic monophosphate sodium salt elevates cAMP levels within the cell, leading to the activation of protein kinase A (PKA), which can phosphorylate downstream targets, including those within the WAVE complex, thereby activating BRICK1. Epidermal Growth Factor (EGF) initiates a signaling cascade via its receptor that results in actin cytoskeleton remodeling, where BRICK1 is a key player. Lithium Chloride activates BRICK1 by inhibiting GSK-3β, potentially leading to the activation of pathways that control actin polymerization. Calyculin A prevents the dephosphorylation of proteins involved in actin dynamics by inhibiting protein phosphatases PP1 and PP2A, which can result in BRICK1 activation. Moreover, Forskolin increases cAMP levels, consequently activating PKA and influencing actin dynamics to enhance BRICK1 activity. Lastly, NSC 23766 and Y-27632 indirectly modulate BRICK1 activity by modulating the availability of Rac1 and inhibiting ROCK, respectively, which both result in altered actin polymerization and activation of the WAVE complex, thereby modulating BRICK1 function.